Our latest articles

Vantage logo

Sarepta loses its Momentum

A clinical hold for the company’s Exondys 51 follow-on adds further pressure on the forthcoming gene therapy readouts.

Vantage logo

To buy or build blockbusters?

A look at blockbuster origins shows the role of external innovation, but more of these huge franchises are in the hands of their inventors than ever before.